EVOLVA BIOTECH A/S: Financial statements 2013
CVR: 25532538
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
EVOLVA BIOTECH A/S (CVR 25532538) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 26,987,702 and a net result of DKK -1,155,567 compared with DKK -1,978,389 the year before. That is an increase of 41.3% compared with the year before. The profit margin was -4.3%. Equity in the 2013 report amounted to DKK 7,088,338. The solvency ratio was 8.7%.
- Revenue
- DKK 26,987,702
- Gross Profit
- DKK 18,890,853
- Profit/Loss
- DKK -1,155,567
- Equity
- DKK 7,088,338
- Total Assets
- DKK 81,901,291
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | 27M | 18.9M | -1.2M | 7.1M | - |
| 2012 | 19.1M | 12.6M | -2M | 8.2M | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
EVOLVA BIOTECH A/S has published its annual report for 2012. Revenue came to DKK 19,095,836, and the net result was DKK -1,978,389.
As of May 3, 2013, Jørgen Hansen has joined the board of directors of EVOLVA BIOTECH A/S.
As of May 3, 2013, Jutta Monika Heim has left the board of directors of EVOLVA BIOTECH A/S.
As of April 17, 2013, Jørgen Hansen is registered as director of EVOLVA BIOTECH A/S.
As of April 17, 2013, Martin Bo Pedersen has stepped down as director of EVOLVA BIOTECH A/S.
About EVOLVA BIOTECH A/S
EVOLVA BIOTECH A/S was a Danish company of the type Aktieselskab based in København Ø, founded in 2000. The company has been dissolved on 17 June 2022. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named ARPIDA A/S and COMBIO A/S. The company has 2 employees (2018). In 2020, the company reported a gross profit of DKK -116,208 and a net result of DKK -196,806 compared with DKK -187,015 the year before. Equity in the 2020 report amounted to DKK 6,378,584.